CLP1 Gene Pontocerebellar Hypoplasia Type 10 Genetic Test
At DNA Labs UAE, we offer the CLP1 Gene Pontocerebellar Hypoplasia Type 10 Genetic Test for individuals experiencing symptoms related to this rare genetic disorder. This test can help diagnose and provide valuable information for genetic counseling and management of the condition.
Test Details
Pontocerebellar hypoplasia, type 10 (PCH10) is a rare genetic disorder characterized by underdevelopment (hypoplasia) of the pons and cerebellum, which are parts of the brain involved in motor control and coordination. This condition is caused by mutations in the CLP1 gene.
Our CLP1 Gene Pontocerebellar Hypoplasia Type 10 Genetic Test utilizes NGS (Next-Generation Sequencing) technology to analyze multiple genes simultaneously. Specifically, it can identify mutations in the CLP1 gene that are responsible for PCH10. This advanced sequencing technology allows for accurate and efficient testing.
Test Components and Price
The CLP1 Gene Pontocerebellar Hypoplasia Type 10 Genetic Test is priced at 4400.0 AED. The test requires a sample of either blood, extracted DNA, or one drop of blood on an FTA card.
Report Delivery and Method
After the sample is obtained, the report will be delivered within 3 to 4 weeks. The test utilizes NGS technology for analysis, ensuring accurate and reliable results.
Test Type and Doctor
The CLP1 Gene Pontocerebellar Hypoplasia Type 10 Genetic Test falls under the category of Neurological Disorders. It is recommended to consult with a Neurologist for this test.
Test Department and Pre-Test Information
The CLP1 Gene Pontocerebellar Hypoplasia Type 10 Genetic Test is conducted in our Genetics department. Before the test, it is important to provide the clinical history of the patient who is going for the test. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by CLP1 Gene Pontocerebellar Hypoplasia, type 10.
Please note that NGS Genetic Testing may not be available in all healthcare settings and may require specialized laboratories or genetic testing facilities. It is recommended to consult with a qualified healthcare professional or geneticist for the interpretation of test results and appropriate counseling based on the individual’s specific genetic findings.
Test Name | CLP1 Gene Pontocerebellar hypoplasia type 10 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CLP1 Gene Pontocerebellar hypoplasia, type 10 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CLP1 Gene Pontocerebellar hypoplasia, type 10 |
Test Details |
Pontocerebellar hypoplasia, type 10 (PCH10) is a rare genetic disorder characterized by underdevelopment (hypoplasia) of the pons and cerebellum, which are parts of the brain involved in motor control and coordination. It is caused by mutations in the CLP1 gene. NGS (Next-Generation Sequencing) Genetic Testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of PCH10, NGS Genetic Testing can be used to identify mutations in the CLP1 gene that are responsible for the condition. NGS Genetic Testing involves obtaining a DNA sample from the patient, typically through a blood or saliva sample. The DNA is then sequenced using NGS technology, which allows for the identification of specific genetic variations or mutations in the CLP1 gene. These mutations can help confirm a diagnosis of PCH10 and provide valuable information for genetic counseling and management of the condition. It is important to note that NGS Genetic Testing may not be available in all healthcare settings and may require specialized laboratories or genetic testing facilities. Additionally, the interpretation of test results should be done by a qualified healthcare professional or geneticist who can provide appropriate counseling and guidance based on the individual’s specific genetic findings. |